Osteosarcoma and metastasis

G Sheng, Y Gao, Y Yang, H Wu - Frontiers in oncology, 2021 - frontiersin.org
Osteosarcoma is the most common primary bone malignancy in adolescents. Its high
propensity to metastasize is the leading cause for treatment failure and poor prognosis …

Matrigel: from discovery and ECM mimicry to assays and models for cancer research

G Benton, I Arnaoutova, J George, HK Kleinman… - Advanced drug delivery …, 2014 - Elsevier
The basement membrane is an important extracellular matrix that is found in all epithelial
and endothelial tissues. It maintains tissue integrity, serves as a barrier to cells and to …

CXCR4 downregulation of let-7a drives chemoresistance in acute myeloid leukemia

Y Chen, R Jacamo, M Konopleva… - The Journal of …, 2013 - Am Soc Clin Investig
We examined the role of microRNAs (miRNAs) in targeting the stromal-derived factor
1α/CXCR4 (SDF-1α/CXCR4) axis to overcome chemoresistance of AML cells. Microarray …

Molecular alterations as target for therapy in metastatic osteosarcoma: a review of literature

J PosthumaDeBoer, MA Witlox, GJL Kaspers… - Clinical & experimental …, 2011 - Springer
Treating metastatic osteosarcoma (OS) remains a challenge in oncology. Current treatment
strategies target the primary tumour rather than metastases and have a limited efficacy in the …

Dissecting the roles and clinical potential of YY1 in the tumor microenvironment

MN Li, JX Wei, CN Xue, XT Zhou, SP Chen… - Frontiers in …, 2023 - frontiersin.org
Yin-Yang 1 (YY1) is a member of the GLI-Kruppel family of zinc finger proteins and plays a
vital dual biological role in cancer as an oncogene or a tumor suppressor during …

Biomarkers of osteosarcoma, chondrosarcoma, and Ewing sarcoma

FR Evola, L Costarella, V Pavone, G Caff… - Frontiers in …, 2017 - frontiersin.org
Osteosarcoma is the most frequent malignant bone neoplasm, followed by chondrosarcoma
and Ewing sarcoma. The diagnosis of bone neoplasms is generally made through …

The oncogenic role of Yin Yang 1

Q Zhang, DB Stovall, K Inoue… - Critical Reviews™ in …, 2011 - dl.begellhouse.com
ABSTRACT Yin Yang 1 (YY1) is a transcription factor with diverse and complex biological
functions. YY1 either activates or represses gene transcription, depending on the stimuli …

KRAS/NF-κB/YY1/miR-489 signaling axis controls pancreatic cancer metastasis

P Yuan, XH He, YF Rong, J Cao, Y Li, YP Hu, Y Liu… - Cancer research, 2017 - AACR
KRAS activation occurring in more than 90% of pancreatic ductal adenocarcinomas (PDAC)
drives progression and metastasis, but the underlying mechanisms involved in these …

Sarcoma spheroids and organoids—promising tools in the era of personalized medicine

G Colella, F Fazioli, M Gallo, A De Chiara… - International journal of …, 2018 - mdpi.com
Cancer treatment is rapidly evolving toward personalized medicine, which takes into
account the individual molecular and genetic variability of tumors. Sophisticated new in vitro …

Yin Yang-1 suppresses invasion and metastasis of pancreatic ductal adenocarcinoma by downregulating MMP10 in a MUC4/ErbB2/p38/MEF2C-dependent …

JJ Zhang, Y Zhu, KL Xie, YP Peng, JQ Tao, J Tang, Z Li… - Molecular cancer, 2014 - Springer
Background Increasing evidence indicates an important role of transcription factor Yin Yang-
1 (YY1) in human tumorigenesis. However, its function in cancer remains controversial and …